Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - License Agreements - Additional Information (Details)

v3.22.1
Commitments and Contingencies - License Agreements - Additional Information (Details) - TMRC - USD ($)
$ in Millions
1 Months Ended
Sep. 30, 2021
May 31, 2021
Sep. 30, 2016
May 31, 2016
Sep. 30, 2015
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Up-front license fee         $ 1.0
Payment of up-front license fee       $ 0.5 0.5
Payments per indication due upon the successful achievement of clinical and regulatory milestones         $ 13.0
Payments made upon achievement of development milestone $ 1.0 $ 2.0 $ 1.0